Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors.
Ma L, Li Y, Shi T, Zhu Z, Zhao J, Xie Y, Wen J, Guo S, Wang J, Ding J, Liang C, Shan G, Li Q, Ge M, Cen S.
Ma L, et al. Among authors: ge m.
Biomed Pharmacother. 2023 Feb;158:114213. doi: 10.1016/j.biopha.2023.114213. Epub 2023 Jan 3.
Biomed Pharmacother. 2023.
PMID: 36916436
Free PMC article.